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Abstract
Background: The purpose of this study was to evaluate the antinociceptive effect of black raspberry
(Rubus occidentalis) fruit extract (ROE) in a rat model of chronic muscle pain and examine the mechanisms involved.
Methods: Adult male Sprague–Dawley rats were used, and chronic muscle pain was induced by two injections
of acidic saline into one gastrocnemius muscle. For the first experiment, 50 rats were randomly assigned to five
groups. After the development of hyperalgesia, rats were injected intraperitoneally with 0.9 % saline or ROE
(10, 30, 100, or 300 mg/kg). For the second experiment, 70 rats were randomly assigned to seven groups. Rats were
injected intraperitoneally with saline, yohimbine, dexmedetomidine, prazosin, atropine, mecamylamine, or naloxone
after the development of hyperalgesia. Ten minutes later, ROE (300 mg/kg) was administered intraperitoneally. For
both experiments, the mechanical withdrawal threshold (MWT) was evaluated with von Frey filaments before the
first acidic saline injection, 24 h after the second injection, and at 15, 30, 45, 60, 80, 100, and 120 min, 24 and 48 h
after the drug administration.
Results: Compared with the control group, the MWT significantly increased up to 45 min after injection of ROE
100 mg/kg and up to 60 min after injection of ROE 300 mg/kg, respectively. Injection of ROE together with
yohimbine or mecamylamine significantly decreased the MWT compared with the effect of ROE alone, while
ROE together with dexmedetomidine significantly increased the MWT.
Conclusions: ROE showed antinociceptive activity against induced chronic muscle pain, which may be mediated
by α2-adrenergic and nicotinic cholinergic receptors.
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Background
Musculoskeletal pain is a significant health issue with con-
siderable costs and impact for individuals and society.
Chronic pain and hyperalgesia induced by musculoskeletal
injuries are managed using a multidisciplinary approach,
but can be disabling and difficult to treat [1]. Recently,
food-based approaches for chronic pain management have
been investigated. Among them, blackberry fruits (Rubus
spp.), has increasingly drawn attention owing to their
high content of anthocyanins and other phenolic
compounds [2]. Anthocyanins, a class of flavonoids, have
anti-inflammatory, antioxidant, antimicrobial, and anti-
carcinogenic properties [3–5], which suggest that Rubus
fruits have a high potential for medical application.
Rubus occidentalis, commonly called black raspberry,
has one of the highest anthocyanin contents among
Rubus spp. and a potent antioxidant capacity [6, 7]. Oxi-
dative stress could play a role in chronic pain, especially
in the musculoskeletal system [8], and the strong anti-
oxidant action of R. occidentalis indicates its therapeutic
potential. In addition, studies have reported antinocicep-
tive effects of other Rubus species [9, 10].
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We hypothesized that R. occidentalis extract (ROE)
would be beneficial for chronic musculoskeletal pain. To
test this hypothesis, we used a rat model of long-lasting
hyperalgesia induced by two intramuscular injections of
acidic saline, which produces bilateral muscle and cuta-
neous mechanical hypersensitivity [11, 12].
The primary outcome of this study was to evaluate the
antinociceptive effect of R. occidentalis in chronic muscle
pain. The secondary outcome was to assess the mecha-
nisms involved in its analgesic activity.
Methods
The present study was performed and described according
to the Animal Research: Reporting In Vivo Experiments
(ARRIVE) statement [13].
Preparation of ROE
The ROE was provided by Gochang Berry & Bio Food
Research Institute (Gochang-gun, Jeollabuk-do, Korea).
Mature fruits of R. occidentalis were collected from
Gochang-gun in South Korea and stored at −20 °C. In
brief, the fruits were extracted twice with 50 % ethanol
at 80 °C by using a reflux condenser, and extracts were
filtered and concentrated. The concentrate was lyophi-
lized in a freeze-dryer and stored at −20 °C until use. All
procedures were conducted under sterilized condition,
and stored ROE was used just before intraperitoneal
injection.
Study animals
The experiment was approved by the Institutional Animal
Care and Use Committee of Chung-Ang University (No.
2015–00009). All experiments were performed in ac-
cordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. Adult male
Sprague–Dawley rats (250–300 g; Coretec, Seoul, Korea)
were single-housed in cages in a temperature-controlled
room (22 °C) and fed a standard laboratory diet and tap
water. They were kept under a 12 h light/dark cycle (lights
on from 8:00 a.m. to 8:00 p.m.) and acclimated to the
housing facilities for 1 week prior to commencing experi-
mental procedures. Rats showing any abnormalities were
excluded.
Induction of hyperalgesia in muscle
All procedures were performed under sterile conditions
by an investigator who was unaware of the group alloca-
tions of the individual rats. Immediately after baseline
behavioral measurements as described below, rats were
anesthetized briefly with 1–4 % isoflurane in 100 % oxy-
gen and injected with 100 μL of pH 4.0 preservative-free
sterile saline into one lateral gastrocnemius muscle on
day 0 and again on day 3. The pH was adjusted to within
3.9 to 4.1 with hydrochloric acid using a SevenEasy
Mettler Toledo pH meter (Mettler Toledo International,
Greifensee, Switzerland) [11].
Drug preparation and administration
One researcher, who was not involved in this study, pre-
pared syringes containing various doses of ROE which
were dissolved in 2 mL of normal saline for ROE groups.
Syringes containing 2 mL of normal saline were pre-
pared for the control group. The syringes were covered
with opaque tape and numbered sequentially according
to a randomization list generated using PASS™ 11 soft-
ware (NCSS, Kaysville, UT, USA). As intraperitoneal
injection is the most frequently used parenteral route of
administration in rats, drugs were intraperitoneally ad-
ministered according to the study protocol. All experi-
mental procedures were conducted by researchers who
were blinded to the group allocation of each animal.
Experiment 1: Evaluation of antinociceptive effect of ROE
The purpose of experiment 1 was to evaluate the anti-
nociceptive effect of ROE on induced chronic muscle
pain. Fifty rats were randomly assigned to one of five
groups of ten rats (control and 10, 30, 100, and 300 mg/kg
ROE). The dose level of ROE was referred to the amounts
used in other experimental studies on the pharmacological
effect of Rubus spp. [14, 15], and fixed based on logarith-
mic increase. Various doses of ROE or normal saline were
injected intraperitoneally 24 h after the second injection
of acidic saline.
In addition, ketorolac of 10 mg/kg was injected intra-
peritoneally in ten rats for the positive control [16]. We
used ten naive rats with no injection of acidic saline for
the negative control.
Experiment 2: Elucidation of mechanism mediating
ROE-induced antinociception
The purpose of experiment 2 was to examine whether
the effects of ROE on mechanical hyperalgesia induced by
repeated intramuscular injections of acidic saline were
mediated by α (1 and 2)-adrenergic, cholinergic (nicotinic
and muscarinic), and/or opioid receptors. The use of
drugs administered to elucidate the possible involvement
of those receptor systems was based on previous studies
[17–20]. The study drugs were purchased from Sigma
Aldrich (U.S.A.). Seventy rats were randomly assigned to
one of seven groups of ten rats, which were injected with
either ROE only (control group) or ROE with normal sa-
line, yohimbine 2 mg/kg, dexmedetomidine 50 μg/kg, pra-
zosin 1 mg/kg, atropine 5 mg/kg, mecamylamine 1 mg/kg,
or naloxone 5 mg/kg, 24 h after the development of
hyperalgesia. Ten minutes later, 300 mg/kg of ROE was
injected intraperitoneally.
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Behavioral measurements
For experiments 1 and 2, individual rats were placed on
an elevated plastic mesh floor (8 × 8 mm perforations)
under an overturned clear plastic cage (21 × 27 × 15 cm)
and allowed to acclimate for 15 min. The rats were then
tested to determine their withdrawal thresholds to
mechanical stimulation using von Frey filaments (Stoelting
Co., Wood Dale, IL, USA). The filaments were applied
vertically to the plantar aspect of the hindpaw by admi-
nistering pressure sufficient to gently bend the filament.
Filaments with bending forces of 4, 9, 20, 59, 78, 98, 147,
and 254 mN were progressively applied until the hindpaw
was withdrawn or a bending force of 254 mN (the cutoff
value) was reached. Each filament was applied three times
at intervals of 3 min. The lowest bending force that
caused paw withdrawal was recorded as the mechan-
ical withdrawal threshold (MWT). After a response
was observed, filaments with higher and lower bend-
ing forces were tested to confirm the MWT. In all
groups, the MWT was assessed before first injection
(BI), 24 h after second injection (AI), and 15, 30, 45,
60, 80, 100, and 120 min, 24 and 48 h after the injection
of the test drugs.
Motor function tests
In order to identify the effect of ROE on motor function
or the sedative effect of ROE, we used an accelerating
Rota-Rod treadmill (Jeung-do Bio & Plant Co., Ltd.,
Seoul, Korea). Fifteen rats were randomly assigned to
one of five groups of three rats (control and ROE 10, 30,
100, and 300 mg/kg). In addition, six rats were used in
Naive and Ketorolac 10 mg/kg groups as positive and
negative controls, respectively. The Rota-Rod test was
performed 30 min after the intraperitoneal administra-
tion of ROE. The rats were placed on the Rota-Rod
treadmill and its speed was gradually increased from one
to 18 rotations per minute (rpm) for 120 s and maintained
for another 30 s at 18 rpm [11]. The time at which the rat
fell off the Rota-Rod was noted.
Sample size calculation
The primary outcome measure of this study was MWT
as assessed using von Frey filaments. To estimate the
required group size for experiment 1, a pilot study was
conducted to measure MWT in 6 hyperalgesia-induced
rats (control group). The averages of the MWT at BI, AI,
15, 30, 45, 60, 80, 100, and 120 min, and 24 and 48 h
after injection of normal saline were 91.5, 20.1, 20.1,
27.4, 27.4, 27.4, 33.0, 27.4, 33.0, 33.0, and 33.0 mN,
respectively. The standard deviations of MWT ranged
from 5.9–20.6 mN, and autocorrelation between adja-
cent measurements on the same subject was approxi-
mately 0.7. For our power calculation, we assumed that
first-order autocorrelation adequately represented the
autocorrelation pattern. We wanted to detect 10, 20, 30,
and 40 % increases in MWT in the ROE 10, 30, 100, and
300 mg/kg groups, respectively, compared with that in
the control group. With an α of 0.05 and a power of
80 %, we calculated that we needed nine rats per group.
Allowing for a drop-out rate of 10 %, we included ten
rats per group.
For experiment 2, sample size estimation was performed
using the results of the study assessing the antinociceptive
effect of ROE. The average MWT in the 300 mg/kg ROE
group at BI, AI, 15, 30, 45, 60, 80, 100, and 120 min, and
24 and 48 h after injection of normal saline were 94.1,
28.8, 59.4, 64.2, 63.9, 53.3, 50.0, 43.3, 39.4, 35.5, 32.1, and
45.5 mN, respectively. The standard deviations of MWT
ranged from 10.5–30.6 mN, and autocorrelation between
adjacent measurements on the same subject was approxi-
mately 0.7. For our power calculation, we assumed that
first-order autocorrelation adequately represented the
autocorrelation pattern. We aimed to detect a 20 % de-
crease of MWT in the ROE with yohimbine, mecamyl-
amine, and dexmedetomidine groups and a 10 % decrease
in the ROE with naloxone, atropine, and prazosin groups.
With an α of 0.05 and a power of 80 %, we calcu-
lated that we needed eight rats per group. Allowing
for a drop-out rate of 10 %, we included ten rats per
group. PASS 11™ software (NCSS) was used to calculate
the sample size.
Statistical analysis
The Shapiro-Wilk test and q-q plot was used to test the
normality of variables. MWT were analyzed using re-
peated measures of ANOVA followed by Tukey test, and
Rota-Rod test were compared using the Kruskal-Wallis
test followed by Bonferroni correction. Individual mea-
surements were expressed as mean ± standard error and
were analyzed using SPSS 20.0 (IBM, Armonk, NY,
USA). A p value of less than 0.05 was considered statisti-
cally significant.
Results
Throughout the experimental period, all rats remained
well-groomed and seemed to maintain normal food and
water intake, and their gait appeared unaffected. Two
injections of pH 4.0 saline into one gastrocnemius muscle
2 days apart resulted in a bilateral decrease in the MWT
(Fig. 1). All rats completed the study and no complications
were observed.
Experiment 1
An intraperitoneal injection of 300 mg/kg of ROE
resulted in a significant increase in the MWT at 15, 30,
45, and 60 min bilaterally, compared with control group
(p = 0.001, <0.001, 0.001, and 0.017 at ipsilateral site,
Fig. 1a, Additional file 1: Table S1; p = 0.001, <0.001,
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0.001 and 0.019 at contralateral site; Fig. 1b, Additional
file 2: Table S2). Compared with the control group, the
100 mg/kg ROE group showed a significant increase in
the MWTat 15, 30 and 45 min bilaterally (p = 0.013, 0.008
and 0.030 at ipsilateral site, Fig. 1a, Additional file 1:
Table S1; p = 0.010, 0.017, and 0.042 at contralateral
site; Fig. 1b, Additional file 2: Table S2).
The MWT significantly reduced in Ketorolac 10 mg/kg
group at AI, 80, 100, and 120 min, 24 and 48 h bilaterally
compared with Naive group (p <0.001, 0.029, <0.001,
<0.001, <0.001, and <0.001 at ipsilateral site, Fig. 2a;
p <0.001, 0.035, <0.001, <0.001, <0.001, and <0.001 at
contralateral site, Fig. 2b). An intraperitoneal injection
of 300 mg/kg of ROE resulted in a significant decrease in
the MWT at AI, 15, 30, 45, 60, 80, 100, and 120 min, 24,
and 48 h bilaterally compared with Naive gorup (p <0.001,
0.002, 0.013, 0.017, 0.003, 0.003, <0.001, <0.001, <0.001,
and <0.001 at ipsilateral site, Fig. 2a; p <0.001, 0.002,
0.016, 0.012, 0.010, 0.007, <0.001, <0.001, <0.001, and
<0.001 at contralateral site, Fig. 2b). There was no signifi-
cant difference between Ketorolac 10 mg/kg and ROE
300 mg/kg groups bilaterally (Fig. 2).
Fig. 1 Antinociceptive effect of Rubus occidentalis extract (a. ipsilateral site, b. contralateral site). Rats were injected intraperitoneally with ROE at
the indicated doses after the development of hyperalgesia. ROE, Rubus occidentalis extract; BI, before injection; AI, after injection, *p < 0.05 compared
with the control group. Data were analyzed using repeated measures of ANOVA followed by Tukey test
Choi et al. BMC Complementary and Alternative Medicine  (2016) 16:202 Page 4 of 10
Experiment 2
In the ROE with mecamylamine group, the MWT sig-
nificantly decreased bilaterally at 15, 30, and 45 min
compared with the ROE only group (p = 0.014, 0.004
and 0.009 at ipsilateral site, Fig. 3a; p = 0.020, 0.001 and
0.004 at contralateral site, Fig. 3b). The MWT decreased
bilaterally in the ROE with yohimbine group at 15, 30
and 45 min compared with the ROE only group (p =
0.018, 0.014 and 0.035 at ipsilateral site, Fig. 4a; p =
0.021, 0.007 and 0.044 at contralateral site, Fig. 4b),
while it increased bilaterally in the ROE with dexmede-
tomidine group at 15, 30, 45 and 60 min (p = 0.009,
0.001 0.001 and 0.038 at ipsilateral site, Fig. 4a;
p = 0.035, 0.012, 0.011 and 0.041 at contralateral site,
Fig. 4b).
Rota-Rod test of motor function
The administration of ROE showed no significant effect
on motor performance as measured by the Rota-Rod test
30 min after intraperitoneal injection of ROE compared
with the control group (p = 0.815). The times to falling
during the Rota-Rod test were 116.67 ± 30.55, 113.00 ±
16.09, 98.00 ± 29.86, 115.33 ± 18.56, 101.00 ± 22.65,
117.33 ± 19.55, and 107.33 ± 17.56 s in the control and
10, 30, 100, 300 mg/kg ROE, Ketorolac 10 mg/kg, and
Naive groups, respectively.
Fig. 2 Antinociceptive effect of Rubus occidentalis extract 300 mg/kg compared with Naive and Ketorolac 10 mg/kg groups (a. ipsilateral site,
b. contralateral site). ROE, Rubus occidentalis extract; BI, before first injection; AI, after second injection, *p < 0.05 compared with the Naive group.
Data were analyzed using repeated measures of ANOVA followed by Tukey test
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Discussion
In the present study, ROE administrated intraperitone-
ally was found to have antinociceptive activity against
hyperalgesia induced by repeated intramuscular injections
of acidic saline, and the strength of the antinociceptive ef-
fect was proportional to the dosage of ROE. Furthermore,
the antinociceptive effect of ROE was significantly reduced
by mecamylamine and yohimbine, and potentiated by
dexmedetomidine, suggesting that the nicotinic choliner-
gic and α2-adrenergic receptors are linked to the analgesic
effect of ROE.
Scientists have elucidated the active components in
Rubus fruits and found that they contain antioxidants
such as anthocyanins, phenolic acid, and ellagitannin
[3, 21]. Rubus occidentalis is particularly rich in an-
thocyanins [2], which are phenolic compounds that
are responsible for the red/purple/black pigmentation
of fruits and vegetables and possess potent antioxidant
activity [22]. This property is associated with potential
benefits for obesity, coronary heart disease, degenerative
disorders, and various types of cancer [3, 6]. Since oxida-
tive stress can influence muscle sensitivity, there may be a
reciprocal interaction between oxidative stress and skeletal
muscle susceptibility to fatigue and pain [8]. Furthermore,
free radicals are known to be associated with pain induc-
tion in chronic pain conditions by causing a decrease in
the threshold of nociceptors locally and thus leading to
hyperalgesia [23, 24]. Hence, the antinociceptive effect of
ROE for chronic musculoskeletal pain and the high antho-
cyanin content of R. occidentalis might be linked. Previous
studies have reported antinociceptive effects of other Ru-
bus spp., strengthening our hypothesis [9, 10]. Our study
Fig. 3 Antinociceptive mechanism of Rubus occidentalis extract together with atropine, mecamylamine, or naloxone (a. ipsilateral site, b. contralateral
site). ROE, Rubus occidentalis extract; BI, before first injection; AI, after second injection. *p < 0.05 compared with the ROE 300 mg/kg group. Data were
analyzed using repeated measures of ANOVA followed by Tukey test
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using a rat model of chronic muscle pain showed an anti-
nociceptive effect of ROE, suggesting that ROE might
have clinical applications for chronic musculoskeletal pain.
Besides, the analgesic effect of ROE was compatible with
that of Ketorolac as a reference analgesic drug in present
study. Ketorolac is a non-steroidal anti-inflammatory
drug that has been available to human use for over
20 years [25]. It has been established as a popular
parenteral analgesic in clinical practice. Also, several
experimental studies in rats evaluated its analgesic ef-
ficacy [26–28]. Thus, similar analgesic effect between ROE
and Ketorolac would support the possibility of clinical use
of ROE.
Chronic musculoskeletal pain poses great therapeutic
challenges for clinicians and imposes high healthcare
costs on a national scale, while reducing working time
and productivity [1]. Additionally, chronic pain can cause
compounding effects by contributing to considerable
psychological problems such as depression and anxiety
[29]. A number of pharmacologic and non-pharmacologic
treatment strategies have been proposed for chronic mus-
culoskeletal pain. However, there is no clearly effective
treatment thus far, and the pharmacological agents
currently used, such as opioids, non-steroidal anti-in-
flammatory drugs, anticonvulsants, and antidepressants,
have limited effectiveness and safety [1, 30]. It is therefore
Fig. 4 Antinociceptive mechanism of Rubus occidentalis extract together with yohimbine, prazosin, or dexmedetomidine (a. ipsilateral site, b. contralateral
site). ROE, Rubus occidentalis extract; BI, before first injection; AI, after second injection. *p < 0.05 compared with the ROE 300 mg/kg group. Data were
analyzed using repeated measures of ANOVA followed by Tukey test
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important to identify new strategies for the treatment of
chronic pain. In this respect, our finding that ROE showed
an antinociceptive effect on chronic musculoskeletal pain
in a rat model could be worthy of notice.
Although the specific mechanisms of chronic muscu-
loskeletal pain are not well understood, the participation
of α-adrenergic and cholinergic systems in several pain-
ful processes is well established [31–33]. To determine
the roles of the α-adrenergic and cholinergic receptors
in the antinociceptive effect of ROE against chronic
musculoskeletal pain in rats, we pretreated the rats with
yohimbine, dexmedetomidine, or prazosin to modulate
the α-adrenergic system or mecamylamine or atropine
to modulate the cholinergic system. Numerous studies
have shown a key role for α2-adrenergic receptor and
its agonists in acute and chronic pain [32], and α2-
adrenoceptor agonist is strongly linked to an antinocicep-
tive effect. Presynaptic activation of α2-adrenoceptor
decreases the release of transmitters from primary afferent
fibers that inhibit the transmission of pain information
[34]. This is correlated with our finding that the antinoci-
ceptive effect of ROE was reversed by yohimbine and
increased by dexmedetomidine, which suggests that α2-
adrenergic receptor mediates the antinociceptive effect of
ROE. Although an analgesic effect can also be induced by
α1-adrenoceptor agonist [33], there seemed to be no sig-
nificant relationship between the analgesic effect of ROE
and prazosin in the present study.
Several studies have demonstrated an antinociceptive
effect of cholinergic receptor activation. Rowley et al.
reported the antinociceptive actions of a nicotinic cho-
linergic agonist [31], which is associated with our finding
that the nicotinic antagonist mecamylamine reversed the
antinociceptive effect of ROE. Although muscarinic agon-
ist can also induce an analgesic effect [35], there was no
significant effect of atropine in the present study.
There were some limitations of the present study.
First, we used a non-inflammatory pain model, but several
studies have reported an anti-inflammatory effect of ROE
[36, 37]. Given that anti-inflammatory effects can contrib-
ute to antinociceptive activity [38], further study using an
inflammatory model of chronic pain would provide fur-
ther information regarding the anti-inflammatory effect of
ROE and its therapeutic value for pain management.
Besides, ROE can attenuate inflammatory responses by re-
ducing the secretion of proinflammatory cytokines, which
can induce pain [39]. However, the development of an ani-
mal model mimicking chronic pain is difficult because
several factors can contribute to chronic pain, unlike acute
pain models in which the cause is clear [40]. The acidic
saline induced pain model used in the current study has
been proposed to have validity as a model of chronic
widespread pain conditions in humans [41]. Second, we
used ripe R. occidentalis fruit in our experiment. Several
studies have investigated the fruits of Rubus spp. accord-
ing to their degree of maturity [2, 42]. Further study of the
antinociceptive activity of ROEs prepared using R. occi-
dentalis fruit at varying stages of maturity would be help-
ful in the future.
Our study had the strength, notwithstanding these
limitations, of being the first experimental study on the
effect of ROE on chronic musculoskeletal pain model in
rats using a rigorous study protocol.
Conclusions
R. occidentalis showed antinociceptive activity against
chronic muscle-induced pain, which may be mediated
by α2-adrenergic and nicotinic cholinergic receptors.
Additional files
Additional file 1: Table S1. Mechanical withdrawal threshold at
ipsilateral site. Rats were injected intraperitoneally with ROE at the
indicated doses after the development of hyperalgesia. ROE, Rubus
occidentalis extract; BI, before injection; AI, after injection. (XLSX 15 kb)
Additional file 2: Table S2. Mechanical withdrawal threshold at
contralateral site. Rats were injected intraperitoneally with ROE at the
indicated doses after the development of hyperalgesia. ROE, Rubus
occidentalis extract; BI, before injection; AI, after injection. (XLSX 15 kb)
Abbreviations
AI, after second injection; ANOVA, analysis of variance; BI, before first
injection; MWT, mechanical withdrawal threshold; ROE, Rubus occidentalis
extract; rpm, rotation per minute; spp, species
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